TNBC, aggressive and lacking key receptors, complicates treatment, impacting prognosis and requiring specialized approaches.

A new PET radiotracer can effectively visualize Nectin-4, an emerging biomarker found in triple-negative breast cancer (TNBC) ...

Hope for aggressive breast cancer. Survivors and doctors discuss breakthroughs, fears, and the need for inclusive research.

Immunotherapy advances in triple-negative breast cancer drive personalized treatments with immune checkpoint inhibitors, ...

or bilateral breast cancer. Clinical and epidemiologic data were collected for patients with TNBC, including age, cancer stage, nodal status, tumor size, diagnosis and treatment timelines, prescribed ...

An expert shares information on a pair of noteworthy active trials in breast cancer that patients should be aware of. For patients with triple-negative breast cancer, there are now several clinical ...

Among patients with early-stage triple-negative breast cancer, a beneficial pathologic complete response rate was higher in ...

In the early 2000s scientists noted the most aggressive tumors lacked the three receptors that respond to hormone therapies and termed this cancer subtype triple-negative breast cancer (TNBC).

Two women’s lives completely changed when they heard the words: “You have cancer.” But what happened next, is surprising.